Literature DB >> 24093784

Bacteriocin from Bacillus subtilis as a novel drug against diabetic foot ulcer bacterial pathogens.

Baby Joseph1, Berlina Dhas, Vimalin Hena, Justin Raj.   

Abstract

OBJECTIVE: To isolate and identify Bacillus subtilis (B. subtilis) from soil and to characterize and partially purify the bacteriocin. To evaluate the antimicrobial activity against four diabetic foot ulcer bacterial pathogens.
METHODS: Genotypic identification was done based on Bergey's manual of systemic bacteriology. Antimicrobial susceptibility test was done by Kirby-Bauer disc diffusion method. Colonies were identified by colony morphology and biochemical characterization and also compared with MTCC 121 strain. Further identification was done by 16S rRNA sequencing. Inhibitory activities of partially purified bacteriocin on all the DFU isolates were done by agar well diffusion method. The strain was identified to produce bacteriocin by stab overlay assay. Bacteriocin was extracted by organic solvent extraction using chloroform, further purified by HPLC and physical, and chemical characterization was performed.
RESULTS: The four isolates showed high level of resistance to amoxyclav and sensitivity to ciprofloxacin. HPLC purification revealed that the extracts are bacteriocin. The phylogenetic tree analysis results showed that the isolate was 99% related to B. subtilis BSF01. The results reveled activity to all the four isolates and high level of activity was seen in case of Klebsiella sp.
CONCLUSIONS: Partially purified bacteriocin was found to have antimicrobial activity against the four diabetic foot ulcer bacterial pathogens, which can thus be applied as a better drug molecule on further studies. The strain B. subtilis are found to be safe for use and these antimicrobial peptides can be used as an antimicrobial in humans to treat DFU bacterial pathogens.
Copyright © 2013 Asian Pacific Tropical Biomedical Magazine. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  16S rRNA; Antimicrobial activity; HPLC; Micrococcus leuteus; Physicochemical characterization

Mesh:

Substances:

Year:  2013        PMID: 24093784      PMCID: PMC3805101          DOI: 10.1016/S2221-1691(13)60183-5

Source DB:  PubMed          Journal:  Asian Pac J Trop Biomed        ISSN: 2221-1691


  13 in total

1.  Biochemical and genetic characterization of coagulin, a new antilisterial bacteriocin in the pediocin family of bacteriocins, produced by Bacillus coagulans I(4).

Authors:  C Le Marrec; B Hyronimus; P Bressollier; B Verneuil; M C Urdaci
Journal:  Appl Environ Microbiol       Date:  2000-12       Impact factor: 4.792

2.  In vitro activity and mode of action of diastereomeric antimicrobial peptides against bacterial clinical isolates.

Authors:  U Pag; M Oedenkoven; N Papo; Z Oren; Y Shai; H-G Sahl
Journal:  J Antimicrob Chemother       Date:  2004-01-16       Impact factor: 5.790

Review 3.  Bacteriocin production: a probiotic trait?

Authors:  Alleson Dobson; Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Appl Environ Microbiol       Date:  2011-10-28       Impact factor: 4.792

4.  Bacteriocin (BAC-IB17): screening, isolation and production from Bacillus subtilis KIBGE IB-17.

Authors:  Asma Ansari; Afsheen Aman; Nadir Naveed Siddiqui; Samina Iqbal; Shah Ali ul Qader
Journal:  Pak J Pharm Sci       Date:  2012-01       Impact factor: 0.684

5.  Australian Diabetes Foot Network: management of diabetes-related foot ulceration - a clinical update.

Authors:  Shan M Bergin; Joel M Gurr; Bernard P Allard; Emma L Holland; Mark W Horsley; Maarten C Kamp; Peter A Lazzarini; Vanessa L Nube; Ashim K Sinha; Jason T Warnock; Jan B Alford; Paul R Wraight
Journal:  Med J Aust       Date:  2012-08-20       Impact factor: 7.738

6.  The association of ulceration of the foot with cardiovascular and all-cause mortality in patients with diabetes: a meta-analysis.

Authors:  J R W Brownrigg; J Davey; P J Holt; W A Davis; M M Thompson; K K Ray; R J Hinchliffe
Journal:  Diabetologia       Date:  2012-08-14       Impact factor: 10.122

7.  Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream.

Authors:  Benjamin A Lipsky; Kenneth J Holroyd; Michael Zasloff
Journal:  Clin Infect Dis       Date:  2008-12-15       Impact factor: 9.079

8.  Bacteriocin synthesis in uropathogenic and commensal Escherichia coli: colicin E1 is a potential virulence factor.

Authors:  David Smajs; Lenka Micenková; Jan Smarda; Martin Vrba; Alena Sevčíková; Zuzana Vališová; Vladana Woznicová
Journal:  BMC Microbiol       Date:  2010-11-15       Impact factor: 3.605

Review 9.  Bacteriocins of gram-positive bacteria.

Authors:  R W Jack; J R Tagg; B Ray
Journal:  Microbiol Rev       Date:  1995-06

10.  Antibacterial activity of some lactic acid bacteria isolated from an Algerian dairy product.

Authors:  Abdelkader Mezaini; Nour-Eddine Chihib; Abdelkader Dilmi Bouras; Naima Nedjar-Arroume; Jean Pierre Hornez
Journal:  J Environ Public Health       Date:  2009-08-12
View more
  7 in total

1.  Probiotics and antimicrobial peptides: the creatures' and substances' future in the twenty-first century: an opinion letter.

Authors:  Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2014-06       Impact factor: 4.609

2.  Bacillus coagulans SANK 70258 suppresses Enterobacteriaceae in the microbiota of ulcerative colitis in vitro and enhances butyrogenesis in healthy microbiota.

Authors:  Kengo Sasaki; Daisuke Sasaki; Jun Inoue; Namiko Hoshi; Takayuki Maeda; Ryouichi Yamada; Akihiko Kondo
Journal:  Appl Microbiol Biotechnol       Date:  2020-03-07       Impact factor: 4.813

Review 3.  Bacillus As Potential Probiotics: Status, Concerns, and Future Perspectives.

Authors:  Fouad M F Elshaghabee; Namita Rokana; Rohini D Gulhane; Chetan Sharma; Harsh Panwar
Journal:  Front Microbiol       Date:  2017-08-10       Impact factor: 5.640

Review 4.  Bacillus subtilis: A plant-growth promoting rhizobacterium that also impacts biotic stress.

Authors:  Abeer Hashem; Baby Tabassum; Elsayed Fathi Abd Allah
Journal:  Saudi J Biol Sci       Date:  2019-05-20       Impact factor: 4.219

5.  Stimulation of Bovicin HC5 Production and Selection of Improved Bacteriocin-Producing Streptococcus equinus HC5 Variants.

Authors:  Sofia Magalhães Moreira; Tiago Antônio de Oliveira Mendes; Hilário Cuquetto Mantovani
Journal:  Probiotics Antimicrob Proteins       Date:  2021-06       Impact factor: 4.609

6.  A novel bacteriocin from Enterococcus faecalis 478 exhibits a potent activity against vancomycin-resistant enterococci.

Authors:  Uraporn Phumisantiphong; Kanokrat Siripanichgon; Onrapak Reamtong; Pornphan Diraphat
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

7.  Can probiotic cleaning solutions replace chemical disinfectants in dental clinics?

Authors:  Farah Al-Marzooq; Shahad Al Bayat; Farah Sayyar; Hamdah Ishaq; Husain Nasralla; Rayan Koutaich; Sausan Al Kawas
Journal:  Eur J Dent       Date:  2018 Oct-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.